Patient has a condition(s) that, in the opinion of the Investigator, would make participation infeasible such as inability to provide informed consent, illiteracy, or inability to speak, read, and write in English.
Patient is on hospice.
Patient is receiving or has received an investigational agent \< 28 days prior to randomization or during this pilot study.
Clareo Health | A Study to Evaluate the My Hematology Oncology Patient Experience (MyHOPE™) For Multiple Myeloma (MM) Digital Care Network in Patients With MM
